BIOMAT Database Logo BIOMAT Database Logo

Quantification of cyclosporin G (NVa2 cyclosporin) by radioimmunoassay. 1986

R W Yatscoff, and J R Jeffery

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

R W Yatscoff, and J R Jeffery
Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC.
June 1993, Clinical chemistry,
R W Yatscoff, and J R Jeffery
Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
February 1993, Clinical chemistry,
R W Yatscoff, and J R Jeffery
Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration.
July 1987, Clinical chemistry,
R W Yatscoff, and J R Jeffery
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
June 1993, Clinical chemistry,
R W Yatscoff, and J R Jeffery
The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
July 1991, Therapeutic drug monitoring,
R W Yatscoff, and J R Jeffery
High-performance liquid chromatographic analysis of cyclosporin G (Nva2-cyclosporine) in human blood.
October 1992, Therapeutic drug monitoring,
R W Yatscoff, and J R Jeffery
Modulation of metabolism in HepG2 cells upon treatment with cyclosporin A and Nva2-cyclosporin.
June 1991, Experimental and molecular pathology,
R W Yatscoff, and J R Jeffery
Monitoring of cyclosporin by monoclonal radioimmunoassay.
September 1988, Lancet (London, England),
R W Yatscoff, and J R Jeffery
[Determination of cyclosporin concentration in blood by radioimmunoassay].
February 1991, Orvosi hetilap,
R W Yatscoff, and J R Jeffery
Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
May 1986, Clinical and experimental immunology,
Copied contents to your clipboard!